Michael Levy

[Michael Levy @MikeAtUSP]

Identifying and removing substandard & falsified medicines is critical to treating #malaria and lessening the spread of AMRs in patient populations. See latest @USPharmacopeia Quality Institute research in @PLOSONE. https://t.co/wuTwmlYtYx

[USP @USPharmacopeia]

Substandard and falsified #medicines may foster #AMR and negative health outcomes. New research from USP's Quality Institute underscores the importance of quality meds in successfully treating #malaria with ACTs, per @WHO guidelines. @PLOSONE https://t.co/3tUrOEP4MO

[USP @USPharmacopeia]

Substandard and falsified #medicines may foster #AMR and negative health outcomes. New research from USP's Quality Institute underscores the importance of quality meds in successfully treating #malaria with ACTs, per @WHO guidelines. @PLOSONE https://t.co/3tUrOEP4MO

[Michael Levy @MikeAtUSP]

@RonPiervincenzi @USPharmacopeia Thank you for the opportunity to talk to all staff about our exciting work!

[USP @USPharmacopeia]

The USP #Pharmacoinformatics Workshop will explore the current and future states for use of digital capabilities across the healthcare environment and opportunities to enhance interoperability to further improve patient outcomes. Register Today. https://t.co/ZZXYYWnJon

[Michael Levy @MikeAtUSP]

@AnneBell . #MedsWeCanTrust

[Michael Levy @MikeAtUSP]

@AnneBell @mhzaman Surrounded by giants! Thank you for the great panel on #amr at #AAAS2019 @mhzaman

[Joris van Dam @DamJoris]

Quality in Digital Therapeutics. Or, the way I paraphrase it to my family: if you had to have a pacemaker, would you like it to run of software from Microsoft, Apple, Google, Philips or Medtronic? @MikeAtUSP @glicholai https://t.co/owbMb1vaPQ

[Michael Levy @MikeAtUSP]

Thrilled to be part of a panel on #digitaltherapeutics with two leaders in the field @DamJoris and @imdavidamor

[Bruk Alemayehu @brukalemayehu]

Left unchecked, poor-quality medicines reverse progress on infectious diseases & #NCDs, erode trust in #healthsystems & increase threat of #AMR. By speaking up for #MedsWeCanTrust, we keep health progress moving forward.

[Ron Piervincenzi @RonPiervincenzi]

At @USPharmacopeia we are working to highlight the role of poor quality antibiotics in driving #Antibioticresistance ... and ways we know to raise quality levels

[Michael Levy @MikeAtUSP]

Come join the Research & Innovation team @USPharmacopeia to work on emerging technologies that may impact quality of medicines, foods, dietary supplements and healthcare -- Director, Proof of Concept (PoC) Lead in Rockville, Maryland, United States https://t.co/POz24D36UN

[Michael Levy @MikeAtUSP]

Digital Therapeutics: How to Ensure Quality in an Emerging Field https://t.co/JNHWUQWkcw @USPharmacopeia @dtx_alliance

[Michael Levy @MikeAtUSP]

Looking Ahead: Emerging Technologies and Quality Standards of Medicines https://t.co/8RRNHK7V5t

[Ron Piervincenzi @RonPiervincenzi]

Excited to co-host with @dtx_alliance today our first ever @USPharmacopeia workshop to explore quality standards for #digitaltherapeutics

[Michael Levy @MikeAtUSP]

That's why it's so important to have access to #MedsWeCanTrust

[Michael Levy @MikeAtUSP]

Critical issue that needs more attention. @USPharmacopeia works to help ensure #medicinequality for all, but more work is needed: Fake And Faulty Drugs: A Problem No One Wants To Talk About https://t.co/b2cNn74KPy @mhzaman @CDDEP

[Michael Levy @MikeAtUSP]

@RonPiervincenzi @GlobalCitizenYr Exciting!!

[Michael Levy @MikeAtUSP]

Join me at #CPhINorthAmerica

[Michael Levy @MikeAtUSP]

Excited to be at CPhI and speaking about technology and quality standards!

[Michael Levy @MikeAtUSP]

I was honored to attend this dinner! https://t.co/oQaAyzdm2t

[Ron Piervincenzi @RonPiervincenzi]

This was one of the highlights of my time at @USPharmacopeia https://t.co/UoWLOTr6oI